UK Markets closed

NFL Biosciences SA (ALNFL.PA)

Paris - Paris Delayed price. Currency in EUR
Add to watchlist
0.7100-0.0560 (-7.31%)
At close: 05:35PM CEST
Full screen
Loading interactive chart…
  • Globe Newswire

    NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea

    NFL BIOSCIENCES: Decision to approve the issuing of its patent in South Korea NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is announcing that it has received approval from the South Korean intellectual property office for issuing its patent (South Korean application no.10-2018-7032224) for NFL-101, a nicotine-free botanical drug candidate comprising natural proteins extracted from tobacco l

  • Globe Newswire

    NFL BIOSCIENCES: Notice of allowance of its patent in China

    NFL BIOSCIENCES: Notice of allowance of its patent in China NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing botanical drugs for the treatment of addictions, is announcing that it has received the notice of allowance from the Chinese National Intellectual Property Administration (CNIPA) for issuing its patent (Chinese application no.201780033409.5) for NFL-101, a nicotine-free botanical drug candidate comprising natural proteins extracted fro

  • Globe Newswire

    NFL Biosciences: 2021 full-year business and earnings update

    NFL Biosciences: 2021 full-year business and earnings update Phase II/III clinical trial rolled out for the drug candidate NFL-101 for smoking cessation: first patients recruited and recruitment capacity ramped up Organization further strengthened and active ingredient manufacturing partnership set up Intellectual property extended with an NFL Biosciences patent registered in the United States Co-development agreement signed for the drug candidate NFL-301 to reduce alcohol consumption NFL BIOSCI